GE HealthCare and Mayo Clinic have launched GEMINI-RT, a joint initiative designed to advance personalized radiation therapy and reshape cancer care. Building on a decades-long partnership and a 2023 strategic research collaboration, the program will focus on innovation in prediction, treatment planning, automation, workflow optimization, and patient monitoring across the radiation oncology continuum.
GEMINI-RT combines Mayo Clinic’s deep clinical and research expertise with GE HealthCare’s engineering and technology capabilities in oncology. Together, they aim to integrate imaging, advanced therapies, dosimetry, and continuous patient monitoring—from diagnosis through follow-up—to deliver more precise, individualized treatment. The initiative will also explore AI-powered tools to reduce repetitive tasks, accelerate treatment planning, and support decision-making. Additional research will focus on combining radiation therapy with emerging treatments such as targeted drugs and precision thermal therapies.
A key ambition is to build connected care models that use AI, biomarkers, and sensors to monitor patients at home, predict side effects earlier, and maintain continuity of care outside the clinic. Mayo Clinic’s Dr. Bryan Traughber described the approach as “twinning the patient, personalizing the beam,” using rich clinical data to model each patient’s journey and tailor therapy with high accuracy. Based at Mayo Clinic’s Rochester campus, GEMINI-RT will leverage the strengths of both organizations in clinical practice, research, and product development. GE HealthCare’s oncology leader Dr. Ben Newton said the collaboration aims to produce clinically meaningful, AI-enabled solutions that improve clinician workflows, enhance patient outcomes, and reduce care-team burnout.
Click here to read the original news story.